Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015

NCT01125917 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

354

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated early due to administrative reasons.

Conditions

Back Pain Lower Back Chronic

Interventions

DRUG: Buprenorphine transdermal patch
DRUG: Buprenorphine transdermal patch
DRUG: Buprenorphine transdermal patch

Sponsor

Purdue Pharma LP